21 May 2009
CTX-M and tem as a predominant type of extended spectrum beta-lactamase among serratia marcescens isolated from solid organ recipients
A Młynarczyk, K Szymanek, A Sawicka-Grzelak, J Pazik, T Buczkowska, M Durlik, B Łągiewska, M Pacholczyk, A Chmura, L Pączek, G MłynarczykAnn Transplant 2009; 14(1): 71-71 :: ID: 880461
Abstract
Background: Serratia marcescens is an important pathogen in hospital infections, especially among patients with impaired immunity. Particularly dangerous are strains producing extended - spectrum beta - lactamases (ESBLs) and carbapenemases. The aim of the work was to establish the percentage of ESBL producing strains of S. marcescens isolated form patients of Transplantation Institute of Transplantology as well as the type of the enzyme.
Material/Methods: The standard clinical microbiology methods were applied to identification and assessment antibiotics susceptibility of S. marcescens isolated from patients of Institute of Transplantology in four years (2005-2008). All strains were examined for ESBL production by several phenotype methods. 28 strains were examined in PCR reaction with starters for most popular types of ESBLs: TEM, SHV, CTX-M.
Results: In total 386 S. marcescens strains from 257 patients were isolated from various specimens form patients from Transplantation Institute. In 2005, 88 patients were infected, and respectively in 2006, 82 patients, in 2007, 57 patients and in 2008, 30. In the case of 188 patients (73%), it was shown by phenotype methods that infecting strain produced ESBL. From 28 strains chosen for molecular analysis 17 produced both CTX-M and TEM beta-lacta-mase, 9 produced only TEM - type, and 2 strains only CTX-M type beta-lacta-mase. Two strains from 2008 were resistant to carbapenems.
Conclusions: In the 2008 the frequency of S. marcescens isolation diminished two times compared to the previous years. The CTX-M-type of ESBL predominated among beta-lactamases produced by the strains. Alarming is the appearance of S. marcescens strains resistant to carbapenems.
In Press
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860